Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betrixaban PK/Safety in NVAF/Atrial Flutter
NCT01229254Phase 2Completed
- Sponsor
- Portola Pharmaceuticals
- Start
- Sep 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of betrixaban in Atrial fibrillation (AFib), atrial flutter (AFL), sponsored by Portola Pharmaceuticals. Started Sep 2010; status: completed.
02
Drugs
betrixaban
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT01229254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01229254.